In prostate cancer, LRP1 expression is observed mostly in tumors with a high Gleason grade, which are the most progressive tumors; however, in hepatocellular carcinoma, a reduction in LRP1 expression may correlate with tumor progression. The gene discussed is LRP1; the disease is prostate cancer.